Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies

被引:32
|
作者
Cheng, Xiangming [1 ]
Gan, Weidong [1 ]
Zhang, Gutian [1 ]
Li, Xiaogong [1 ]
Guo, Hongqian [1 ]
机构
[1] Nanjing Univ, Sch Med, Affiliated Hosp, Dept Urol,Nanjing Drum Tower Hosp, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
来源
BMC UROLOGY | 2016年 / 16卷
基金
中国国家自然科学基金;
关键词
Age groups; Carcinoma; Gender identity; Renal cell; Xp11.2; translocation; APART FISH ASSAY; AGGRESSIVE COURSE; ADULTS; CHILDREN; EXPERIENCE; DIAGNOSIS; FEATURES;
D O I
10.1186/s12894-016-0154-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Renal cell carcinoma (RCC) associated with Xp11.2 translocation/TFE3 gene fusion (Xp11.2 RCC) is a rare subtype of RCC which is firstly described as a distinct entity in 2004 so that clinical characteristics of Xp11.2 RCC in different gender and age are unknown. The purpose of systematic review and meta-analysis is to provide a comprehensive assessment on them. Methods: MEDLINE, EMBASE and Cochrane databases were searched for studies which evaluate the clinical characteristics of Xp11.2 RCC. The literature published between July 2004 and May 2014 was searched. Results: A total of 15 studies with 147 participants were included. The meta-analysis demonstrated that number of patients of all age in female was higher than in male with pooled OR of 3.93(95 % CI = 1.66-9.34). However, incidence of distant metastases (OR = 0.34, 95 % CI = 0.12-1.57) and lymphatic metastases (OR = 0.51, 95 % CI = 0.14-1.91), tumor stage (OR = 0.85, 95 % CI = 0.34-2.15) and overall survival (OS) (OR = 0.46, 95 % CI = 0.05-4.34) between male and female were comparable. Incidence in female was higher than in male with pooled OR of 5.13(95 % CI = 1.67-15.72) in adults, while in children no gender-related predominance (OR = 1.19, 95 % CI = 0.38-3.72) was observed. In addition, incidence of distant metastases (OR = 1.00, 95 % CI = 0.13-7.84) and lymphatic metastases (OR = 1.00, 95 % CI = 0.07-13.67) and tumor stage (OR = 1.94, 95 % CI = 0.20-19.03) between children and adults were comparable. Survival curves presented comparable outcomes between male and female (P = 0.707) as well as between children and adults (P = 0.383). Conclusions: Female patients with Xp11.2 RCC in adults exhibit a high incidence compared to male, but not in children. Comparable clinical characteristics including incidence of distant and lymphatic metastases, tumor stage and prognosis is presented between male and female as well as between children and adults.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Clinical characteristics of XP11.2 translocation/TFE3 gene fusion renal cell carcinoma: a systematic review and meta-analysis of observational studies
    Xiangming Cheng
    Weidong Gan
    Gutian Zhang
    Xiaogong Li
    Hongqian Guo
    BMC Urology, 16
  • [2] Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusions: clinical experience and literature review
    He, Jian
    Chen, Xiancheng
    Gan, Weidong
    Zhu, Bin
    Fan, Xiangshan
    Guo, Hongqian
    Jia, Ruipeng
    FUTURE ONCOLOGY, 2015, 11 (24) : 3243 - 3252
  • [3] Pseudocapsule of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: a clue for tumor enucleation?
    Cheng, Xiangming
    He, Jian
    Gan, Weidong
    Fan, Xiangshan
    Yang, Jun
    Zhu, Bin
    Guo, Hongqian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2015, 8 (05): : 5403 - 5410
  • [4] Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis
    Liu, Ning
    Wang, Zhen
    Gan, Weidong
    Xiong, Lei
    Miao, Baolei
    Chen, Xiancheng
    Guo, Hongqian
    Li, Dongmei
    PLOS ONE, 2016, 11 (11):
  • [5] Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma with a micropapillary pattern: cases report and literature review
    Xu, Zhou-Yi
    Wang, Jing-Ping
    Zhang, Yu
    Wu, Shi-Wu
    Ma, Li
    Qin, Yan-Zi
    Wang, Z. Peter
    Chai, Da-Min
    Tao, Yi-Sheng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (01): : 327 - 339
  • [6] Ultrasonographic Findings of Renal Cell Carcinomas Associated with Xp11.2 Translocation/TFE3 Gene Fusion
    Ling, Wenwu
    Ma, Xuelei
    Luo, Yan
    Chen, Linyan
    Wang, Huiyao
    Wang, Xiaoling
    Chen, Ni
    Zeng, Hao
    Li, Yongzhong
    Cai, Diming
    CONTRAST MEDIA & MOLECULAR IMAGING, 2017,
  • [7] Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion
    Wang, Wei
    Ding, Jianhui
    Li, Yuan
    Wang, Chaofu
    Zhou, Liangping
    Zhu, Hui
    Peng, Weijun
    PLOS ONE, 2014, 9 (06):
  • [8] Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion 3 case reports and review of literature
    Gong, Pengfeng
    Zhuang, Qianfeng
    Wang, Kun
    Xu, Renfang
    Chen, Yiming
    Wang, Xiaogang
    Yin, Shuai
    MEDICINE, 2018, 97 (24)
  • [9] Multimodality imaging of Xp11.2 translocation/TFE3 gene fusion associated with renal cell carcinoma: a case report
    Huang, Wenpeng
    Peng, Yushuo
    Zhang, Yongbai
    Qiu, Yongkang
    Liu, Yi
    Wang, Aixiang
    Kang, Lei
    FRONTIERS IN MEDICINE, 2023, 10
  • [10] Renal cancer associated with Xp11.2 translocation/TFE3 gene fusion: Clinicopathological analysis of 13 cases
    Feng, Runlin
    Tao, Yanping
    Chen, Yuan
    Xu, Wenkai
    Zhang, Guifu
    Wang, Haifeng
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2022, 58